# GD-11 for Injection in the Treatment of Acute Ischemic Stroke

Study · id `cardio:ct-nct06299579` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06299579](<https://clinicaltrials.gov/study/NCT06299579>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06299579

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 980 participants.

## Technical summary

Registry record NCT06299579. Randomized; triple masking; primary purpose treatment. Start 2024-02-29 (actual); primary completion 2025-02-22 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 980 participants (planned count; ClinicalTrials.gov record NCT06299579, source copy `cardio:ctgov-nct06299579-2024-03-15`, retrieved 2026-10-26)
- Started: 2024-02-29 (actual) (ClinicalTrials.gov record NCT06299579, source copy `cardio:ctgov-nct06299579-2024-03-15`, retrieved 2026-10-26)
- Primary completion: 2025-02-22 (anticipated) (ClinicalTrials.gov record NCT06299579, source copy `cardio:ctgov-nct06299579-2024-03-15`, retrieved 2026-10-26)
- Completion: 2025-12-31 (anticipated) (ClinicalTrials.gov record NCT06299579, source copy `cardio:ctgov-nct06299579-2024-03-15`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06299579, source copy `cardio:ctgov-nct06299579-2024-03-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06299579-2024-03-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: GD-11 for Injection in the Treatment of Acute Ischemic Stroke
- Condition: Acute Ischemic Stroke
- Intervention (Drug): GD-11 for injection test group
- Intervention (Drug): Placebo control group
- Lead sponsor: Beijing Tiantan Hospital
- Lead sponsor class: OTHER
- Collaborator: Jiangsu Wangao Pharmaceutical Co. ltd
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)

## Provenance

Content hash: a4dd077ba695aa4da15101659adf4d09b32df7d921f860c3aa946e65bdcdfec9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
